echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tosunshine: Atorvastatin calcium tablets, a holding subsidiary, obtained a drug registration certificate

    Tosunshine: Atorvastatin calcium tablets, a holding subsidiary, obtained a drug registration certificate

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 28, Dongyang Sunshine announced that its holding subsidiary, atorvastatin calcium tablets, obtained the drug registration certificate


    Atorvastatin calcium is suitable for hypercholesterolemia and can reduce the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization, hospitalization due to congestive heart failure, and angina


    Atorvastatin is a category B product in the 2020 edition of the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog, and it is also a cardiovascular system drug in the 2018 edition of the National Essential Medicines List


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.